Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc       US29382F2020

SummaryNewsCalendarCompany 
Business Summary
Develops pharmaceutical drugs for treating cancer & inflammatory diseases

CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases.

Its drug candidate, ENMD 2076, which is an Aurora A and angiogenic kinase inhibitor for the treatment of cancer.

The company was founded in 1991 and is headquartered in Rockville, MD.

Number of employees : 16 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Therapeutics0.669100%---
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States0.669100%---
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD552012Chief Executive Officer & Director
Wei-Wu He PhD, MBA492012Executive Chairman
Cynthia Wong Hu442006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA442011Chief Accounting Officer & Vice President-Finance
William E. Gannon Jr., MD-2012Vice President-Medical & Regulatory Affairs
Jennie C. Hunter-Cevera, PhD662001Independent Director
Tak W. Mak, PhD672012Director
James Z. Huang, MBA482013Independent Director
Yue Alexander Wu PhD, MBA502013Independent Director
Franklin Cary Salisbury, Jr.-2014Director
Shareholders
NameShares%
IDG Capital Partners Co., Ltd. 6,842,78321.1%
Spectrum Pharmaceuticals, Inc. 5,405,38216.7%
Celgene Corp. 2,464,9877.60%
Wellington Shields Capital Management LLC 851,7052.63%
Sabby Capital LLC 788,4852.43%
Wellington Shields & Co. LLC 518,5831.60%
Emerging Technology Partners LLC 441,0721.36%
Kleiner Perkins Caufield & Byers LLC 416,6661.28%
The Vanguard Group, Inc. 400,0601.23%
Tak W. Mak, PhD 365,3761.13%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
PHARMACYCLICS, IN..
ALKERMES PLC
ISIS PHARMACEUTIC..
QUINTILES TRANSNA..
ALNYLAM PHARMACEU..
UNITED THERAPEUTI..
PUMA BIOTECHNOLOG..
-
COVANCE INC.
QIAGEN NV
SYNAGEVA BIOPHARM..
SEATTLE GENETICS,..
ICON PLC
BIO-TECHNE CORP
PAREXEL INTERNATI..
BB BIOTECH AG
CHARLES RIVER LAB..
INTREXON CORP
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
Sector Biotechnology & Medical Research
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2015 Factset   
Dynamic quotes  
ON
| OFF